CTSI Program Director is New Chair-Elect of National BERD ACTS Group
Shari Messinger Cayetano, Ph.D.
CTSI Director of the Biostatistics, Epidemiology and Research Design Program, Shari Messinger Cayetano, Ph.D., was elected Chair-Elect of the Biostatistics, Epidemiology, and Research Design (BERD) Special Interest Group (SIG) of the Association for Clinical and Translational Science (ACTS).
The group brings the biostatistics, epidemiology and research methods community together with the broader spectrum of clinical and translational scientists and serves as a forum for the exchange of information on current approaches to the integration of biostatistics, epidemiology, and research design into clinical and translational science research programs.
As Chair-Elect and part of a five-member Executive Committee, Messinger Cayetano, who is also Associate Professor in the Division of Biostatistics, Department of Public Health Sciences and Director of the Biostatistics Collaboration and Consulting Core at the Miller School of Medicine, will serve in the position for two years supporting the Chair.
Following that time, she will assume the role as Chair, providing guidance and direction for the group including leading events at the annual Translational Science Meeting. After the Chair commitment has been completed, she will transition to Past Chair for an additional two years.
“I am extremely passionate about shifting the perception of biostatistical involvement from that of a service to that of science. Within many academic medical centers, there is often the perception that biostatisticians provide a service to researchers rather than the perception that we are integrating scientific expertise into the research,” said Messinger Cayetano. “The BERD SIG group is extremely well positioned within the CTSA consortium to be able to change the way biostatisticians are perceived through education, communication and engagement. As Chair-Elect and subsequently Chair, I will advocate for the role of biostatisticians as scientists and collaborators, bringing critical expertise to clinical and translational research.”
The ACTS is a platform for enhancing education, research, and public policy related to clinical and translational science through meetings, publications, and collaborative efforts. Its members consist of leaders, investigators, and trainees from academic medical centers, including Clinical Translational Science Award Hubs, as well as government, industry, and philanthropy.